logo

NVCR

Novocure·NASDAQ
--
--(--)
--
--(--)
1.69 / 10
Underperform

NVCR's fundamental score is 1.7/10, reflecting poor financial health. Key positives include a 100% net profit attributable to shareholders ratio and strong cash-up momentum, but these are outweighed by negative factors like low Revenue-MV (-0.1251) and Net income-Revenue (-0.1668). The company's ROA is deeply negative at -8.5879%, and the asset-to-market value ratio is -0.5007, all of which place NVCR in historically underperforming quartiles. These metrics collectively indicate significant fundamental risk.

Fundamental(1.69)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.13
Score0/3
Weight16.78%
1M Return-3.84%
ROA (%)
Value-8.59
Score1/3
Weight2.79%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight7.69%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight10.86%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight18.74%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-11.45
Score1/3
Weight2.79%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.67%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight3.02%
1M Return-0.63%
Cash-MV
Value-0.76
Score1/3
Weight20.59%
1M Return-5.64%
Net profit / Total profit (%)
Value117.24
Score2/3
Weight8.07%
1M Return-1.71%
Is NVCR undervalued or overvalued?
  • NVCR scores 1.69/10 on fundamentals and holds a Premium valuation at present. Backed by its -31.85% ROE, -27.66% net margin, -6.39 P/E ratio, 3.33 P/B ratio, and -15.83% earnings growth, these metrics solidify its Underperform investment rating.